Sponsored Post

Who’s innovating in medication management for the 50+ market? You decide

MedCity and AARP are collaborating to find the top people, ideas and companies that are innovating for the 50+ market. Here’s our first installment of a reader survey that looks at how medication management is seeing disruption. Pick your favorite.

AARP

Back in October, MedCity announced that it was partnering with AARP to unearth the people, ideas and companies that are innovating for the vital and growing 50+ market.

We started the nomination process and more than 150 entries were collected through Nov. 30. Now through stages, we want to arrive at the final Innovation 50+ Leaders.

This week we are inviting readers to pick their favorites among companies and people innovating in the Medication Management category.

Here are our nominees:

COMPANIES

Zipdrug 

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

Omnicell Medication Adherence

RxAssurance Corporation

TowerView Health

WatchRx Inc.

ENTREPRENEURS

Tom Kottler,  founder and CEO of HealthPrize Technologies

Susan Perry, CEO and principal inventor, SpeechMED

Dr. Anthony (Tony) Sterns, CEO of iRx Reminder

Charles Lee, MD,  Founder & President of Polyglot Systems, Inc.

Here is the link where you can find details of the entries and choose your favorites. Voting in the Medication Management category will remain open until 9 ET, Thursday, December 21.